Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent

被引:58
作者
Atigadda, VR
Brouillette, WJ [1 ]
Duarte, F
Ali, SM
Babu, YS
Bantia, S
Chand, P
Chu, N
Montgomery, JA
Walsh, DA
Sudbeck, EA
Finley, J
Luo, M
Air, GM
Laver, GW
机构
[1] Univ Alabama, Dept Chem, Birmingham, AL 35294 USA
[2] Univ Alabama, Ctr Macromol Crystallog, Birmingham, AL 35294 USA
[3] BioCryst Pharmaceut Inc, Birmingham, AL 35244 USA
[4] Univ Oklahoma, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA
[5] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia
关键词
D O I
10.1021/jm980707k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
On the basis of the lead compound 4-(N-acetylamino)-3-guanidinobenzoic acid (BANA 113), which inhibits influenza A sialidase with a K-i of 2.5 mu M, several novel aromatic inhibitors of influenza sialidases were designed. In this study the N-acetyl group of BANA 113 was replaced with a 2-pyrrolidinone ring, which was designed in part to offer opportunities for introduction of spatially directed side chains that could potentially interact with the 4-, 5-, and/or 6-subsites of sialidase. While the parent structure 1-(4-carboxy-2-guanidinophenyl)pyrrolidin-2-one (8) was only a modest inhibitor of sialidase, the introduction of a hydroxymethyl or bis-(hydroxymethyl) substituent at the C5' position of the 2-pyrrolidinone ring resulted in inhibitors (9 and 12, respectively) with low micromolar activity. Crystal structures of these inhibitors in complex with sialidase demonstrated that the substituents at the 5'-position of the 2-pyrrolidinone ring interact in the 4- and/or 5-subsites of the enzyme. Replacement of the guanidine in 12 with a hydrophobic 3-pentylamino group resulted in a large enhancement in binding to produce an inhibitor (14) with an IC50 of about 50 nM against influenza A sialidase, although the inhibition of influenza B sialidase was 2000-fold less. This represents the first reported example of a simple, achiral benzoic acid With potent (low nanomolar) activity as an inhibitor of influenza sialidase.
引用
收藏
页码:2332 / 2343
页数:12
相关论文
共 34 条
[1]   ANTIGENIC, SEQUENCE, AND CRYSTAL VARIATION IN INFLUENZA-B NEURAMINIDASE [J].
AIR, GM ;
LAVER, WG ;
LUO, M ;
STRAY, SJ ;
LEGRONE, G ;
WEBSTER, RG .
VIROLOGY, 1990, 177 (02) :578-587
[2]   THE NEURAMINIDASE OF INFLUENZA-VIRUS [J].
AIR, GM ;
LAVER, WG .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1989, 6 (04) :341-356
[3]   A CONVENIENT SYNTHESIS OF HINDERED AMINES AND ALPHA-TRIFLUOROMETHYLAMINES FROM KETONES [J].
BARNEY, CL ;
HUBER, EW ;
MCCARTHY, JR .
TETRAHEDRON LETTERS, 1990, 31 (39) :5547-5550
[4]   3-DIMENSIONAL STRUCTURE OF INFLUENZA-A N9 NEURAMINIDASE AND ITS COMPLEX WITH THE INHIBITOR 2-DEOXY 2,3-DEHYDRO-N-ACETYL NEURAMINIC ACID [J].
BOSSARTWHITAKER, P ;
CARSON, M ;
BABU, YS ;
SMITH, CD ;
LAVER, WG ;
AIR, GM .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 232 (04) :1069-1083
[5]  
BROUILLETTE WJ, 1999, IN PRESS BIOORG MED
[6]   THE 2.2-A RESOLUTION CRYSTAL-STRUCTURE OF INFLUENZA-B NEURAMINIDASE AND ITS COMPLEX WITH SIALIC-ACID [J].
BURMEISTER, WP ;
RUIGROK, RWH ;
CUSACK, S .
EMBO JOURNAL, 1992, 11 (01) :49-56
[7]   SYNTHESIS OF SUBSTITUTED BETA-AND GAMMA-LACTAMS [J].
CHATTERJEE, BG ;
RAO, VV ;
MAZUMDAR, BN .
JOURNAL OF ORGANIC CHEMISTRY, 1965, 30 (12) :4101-+
[8]   STRUCTURE OF THE CATALYTIC AND ANTIGENIC SITES IN INFLUENZA-VIRUS NEURAMINIDASE [J].
COLMAN, PM ;
VARGHESE, JN ;
LAVER, WG .
NATURE, 1983, 303 (5912) :41-44
[9]   Site-directed mutagenesis of catalytic residues of influenza virus neuraminidase as an aid to drug design [J].
Ghate, AA ;
Air, GM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 258 (02) :320-331
[10]   Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza [J].
Hayden, FG ;
Treanor, JJ ;
Betts, RF ;
Lobo, M ;
Esinhart, JD ;
Hussey, EK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (04) :295-299